
Opinion|Videos|June 18, 2024
Navigating Therapy Approval for Early Breast Cancer: An Operational Perspective
Medical experts discuss their perspectives on therapy approval and the significance of formulary inclusion, emphasizing the need to carefully consider both toxicities and benefits, which may ultimately lead to the operationalization of a drug in clinical practice.
Advertisement
Episodes in this series

Video content above is prompted by the following questions:
How will the potential approval of ribociclib for early breast cancer change your treatment paradigms?
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Newly Approved Specialty Drugs Advance Care for Inflammatory and Autoimmune Diseases
2
Data Suggest Routine Multicancer Early Detection Tests Could Reduce Late–Stage Diagnoses
3
Measles On the Rise: Global Surge and US Status at Risk
4
November 2025 Trending Products
5

















































































































































































































